French American Biotech Symposium on “New Therapeutic and Vaccine Approaches in Infectious Diseases” – La Jolla- April 2, 2008
The first edition of the FABS (French American Biotech Symposium) on “New Therapeutic and Vaccine Approaches in Infectious Diseases” took place at the Salk Institute for Biological Studies, La Jolla, CA, on April 2, 2008.
This event was organized by the Office for Science and Technology, and Lyonbiopole, a French competitiveness cluster dedicated to infectious diseases, in partnership with the Salk Institute and French BioBeach, a local organization that fosters academic and business partnerships between San Diego’s entrepreneurial spirit and France’s expertise in the life sciences.
The ultimate goal of this meeting was to promote the French-American cooperation between scientists and biotech companies and to facilitate growth of innovative partnerships.
The symposium was inaugurated by the Professor Roger Guillemin, Nobel Prize in Medicine, Interim President of The Salk Institute, and by Mr Philippe Larrieu, Consul General of France in Los Angeles. The meeting was divided in 4 sessions, each of them chaired by renowned scientists, and welcomed highly skilled researchers from academic labs or biotech companies, who displayed their work in progress.
More than one hundred people attended this meeting and contributed to the enrichment of debates and discussions. Some French-American partnerships projects were initiated at this occasion.
The day concluded with the common agreement to organize the upcoming FABS on the same topic in France next year.
A symposium “biz” was organized by French BioBeach, the Economic Department of the French Embassy in the U.S and the Invest in France Agency on “New ways to improve IP portfolio for US-based Firms: Internalization of the French competitiveness clusters”.
Visits of research centers based in La Jolla, organized by the Office for Science and Technology, ended these three days of French-American meetings.